Immunolabeling of Cells and Transmission Electron Microscopy - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Immunolabeling of Cells and Transmission Electron Microscopy

Description:

Immunolabeling of Cells and Transmission Electron Microscopy Ike Miguel June 30, 2006 ABE Workshop 2006 Purpose Using TEM to label specific sites in Arabidopsis thaliana. – PowerPoint PPT presentation

Number of Views:260
Avg rating:3.0/5.0
Slides: 23
Provided by: abeLeewar
Category:

less

Transcript and Presenter's Notes

Title: Immunolabeling of Cells and Transmission Electron Microscopy


1
Immunolabeling of Cells and Transmission Electron
Microscopy
  • Ike Miguel
  • June 30, 2006
  • ABE Workshop 2006

2
Purpose
  • Using TEM to label specific sites in Arabidopsis
    thaliana.
  • Goal
  • Overview of Immunolabeling
  • Preparation of samples and viewing
  • Observations of results
  • Thoughts

3
Antibodies are used in immunolabeling of cells
  • Immunoglobulins, or antibodies, detect foreign
    bodies and attach at specific sites called
    epitopes
  • Antibodies fused to myeloma cells where they are
    cloned indefinitely and screened
  • in vitro and in vivo
  • Indirect method used to our purposes

4
Antibody Structure
  • 4 polypeptide chains
  • Two light, VL and CL
  • 2 heavy chains determine fuctional activity in
    vivo
  • IgG, IgA, IgM, IgE, IgD

5
Use of Antibodies for Immunolabeling
  • High level of specificity needed due to
    non-covalent, weak bonding
  • Eliminate non-specific binding
  • Optimal conditions include reagants, pH, heat.
  • Controls are very important!
  • Negative controls to discriminate non-specific
    binding

6
Tranmission Electron Microscopy
  • Zeiss 10/A conventional TEM
  • Easy operation
  • Uses film for images
  • LEO 912 Energy-Filtering TEM
  • Little as 0.5um sections
  • EELS, ESI
  • Digital images
  • Ultramicrotomy, 60-90nm sectioning in resin

7
Immunolabeling with Gold by Indirect Method
  • Gold small, round and dense
  • Easily detectable
  • 110 and 1100 colliodal gold-labeled conjugated
    to primary antibody

8
Preparation of Specimens by Embedding
  • Preparation is limiting factor!
  • Chemical fixation with aldehydes which
    cross-links proteins
  • Paraformaldehyde for grids
  • Dehydrate
  • Infiltrate with resin
  • Polymerize
  • May stain prior to polymerization
  • 7 10 days to fix. May need to repeat.

9
Ultramicrotomy and transfer to grids
  • Glass knife can cut ucron thick sections
  • Diamond knife can cut as small as 2-3um
  • Our samples 80nm 1um thick
  • 60-80nm max thickness for transmission of light
  • 2 sections embedded per grid
  • Avg of 6 sections per grid (2 20)

10
Post-Embedding and Labeling of Specimens
  • Dilution series and controls!
  • Sectioned on Formvar coated grids
  • Pretreat and etch with Na-metaperiodate/
    PBS-glycine
  • Wash with TBST (detergent, ampiphatic, nonionic)
  • Block with milk (lipid, naturally sticky)
  • 1o antibody
  • Wash with TBST
  • 2o antibody, colliodal-gold
  • Wash with TBS and H20 to rinse any Ppt

11
TEM LEO912 Energy-Filtering TEM
  • Tungsten cathode used to produce electron
    illumination source
  • Nitrogen for carbon residue
  • Accelerated through column
  • EMF used to bend and focus illumination
  • Grid sample on objective lense
  • Projector lense produces visible light
  • Beam strikes CCD strip for histogram results

12
GFP, DTT treated
  • Grid 1 No pretreatment, 110 anti-GFP (1o-Ab),
    110 gold (2o-Ab)
  • DTT dithiothritol used to denature GFP
  • Expected labeling on ER, vacuole, or vesicles.
  • What is this?

Fig. 1 Numerous binding to organelle. Group 1.
13
GFP DTT non-specific binding
  • Grid 2 Glycine, 110 anti-GFP (1o-Ab), 110 gold
    (2o-Ab) labeling
  • Non-specific binding is expected result
  • Thoughts?
  • Vascular system or chloroplast

Fig. 2 Non-specific binding
14
Group 2 GFP no DTT treatment
Grid 3. No pretreatment, 110 anti-GFP, 1100
gold. Possible labeling on vacuole.
Grid 4. Na-Periodate, 1100 anti-GFP, 1100 gold.
Random labeling
15
PDI2
  • Expected labeling on starch granules
  • No pretreatment
  • At high concentrations primary antibody may have
    a large number of non-specific binding.

Grid 1. No pretreatment, 110 anti-PDI-2, 110
gold. Observing non-specific binding. Group 3
16
Group 3 PDI2
Grid 1. A lot of non-specific binding but closer
observations may give insight.
17
Group 4 PDI2
Grid 4. Na-Periodate, 110 anti-PDI2, 11000?
gold. Labeling of starch granules
18
Group 4 Control
Grid 4. Control with no primary antibody.
19
Group 4 CNGC
  • Cyclic nucleotide gated channel
  • Allows passage of K
  • Expected labeling on plasma membrane

Grid 2. Glycine, 110 anti-CNGC, 110 gold
20
Group 4 CNGC
Grid 2. Gycine, 110 anti-CNGC, 110 gold.
Possible communication.
21
CNGC
Grid 3. No pretreatment, 110 anti-CNGC, 1100
gold. Group 4
22
Errors and Conclusion
  • Preparation is the limiting factor!
  • Gold labeling antibody may have been prepared in
    the wrong concentrations.
  • A set of new dilutions may be needed.
Write a Comment
User Comments (0)
About PowerShow.com